| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/24/2011 | US20110288127 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 11/24/2011 | US20110288126 Substituted dioxopiperidinyl phthalimide derivatives |
| 11/24/2011 | US20110288122 Pharmaceutical Compositions and Administrations Thereof |
| 11/24/2011 | US20110288117 Substituted hydroxamic acids and uses thereof |
| 11/24/2011 | US20110288116 Iap inhibitors |
| 11/24/2011 | US20110288109 New compounds |
| 11/24/2011 | US20110288108 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 11/24/2011 | US20110288102 Il-8 biomarker for monitoring cancer treatment |
| 11/24/2011 | US20110288097 Pyrrolopyrazine Kinase Inhibitors |
| 11/24/2011 | US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 11/24/2011 | US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
| 11/24/2011 | US20110288091 Soluble mtor complexes and modulators thereof |
| 11/24/2011 | US20110288090 Inhibitors of AKT Activity |
| 11/24/2011 | US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| 11/24/2011 | US20110288086 Polycyclic quinazolines, preparation thereof, and use thereof |
| 11/24/2011 | US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase |
| 11/24/2011 | US20110288080 Nitrofuran Compounds for the Treatment of Cancer and Angiogenesis |
| 11/24/2011 | US20110288078 Pyrazinopyrazines and derivatives as kinase inhibitors |
| 11/24/2011 | US20110288077 Compounds for the treatment of inflammatory diseases |
| 11/24/2011 | US20110288076 Sphingosine-1-Phosphate Receptor Antagonists |
| 11/24/2011 | US20110288071 Substituted pyrimidines for the treatment of diseases such as cancer |
| 11/24/2011 | US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 11/24/2011 | US20110288067 Pyrrolopyrazine Kinase Inhibitors |
| 11/24/2011 | US20110288065 Aminopyrazine derivative and medicine |
| 11/24/2011 | US20110288061 Triterpenoid derivatives, benzenoid derivatives and pharmaceutical compositions containing the same |
| 11/24/2011 | US20110288060 apparatus and process for producing crystals |
| 11/24/2011 | US20110288057 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 11/24/2011 | US20110288052 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 11/24/2011 | US20110288050 Protein phosphatase inhibitor |
| 11/24/2011 | US20110288040 Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors |
| 11/24/2011 | US20110288038 Hesperidin-containing composition |
| 11/24/2011 | US20110288033 Disulfide Compounds for Phototherapy |
| 11/24/2011 | US20110288032 Enzastaurin for the treatment of cancer |
| 11/24/2011 | US20110288023 Cancer drug delivery using modified transferrin |
| 11/24/2011 | US20110288021 Administration of angiocidin for the treatment of cancer |
| 11/24/2011 | US20110288015 Treatment of renal dysfunction and multiple myeloma using pacap compounds |
| 11/24/2011 | US20110288011 Peptide therapeutic conjugates and uses thereof |
| 11/24/2011 | US20110288006 Peptides and methods for inducing cell death |
| 11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
| 11/24/2011 | US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT |
| 11/24/2011 | US20110287112 Prostate cancer progression inhibitor and progression inhibition method |
| 11/24/2011 | US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
| 11/24/2011 | US20110287110 Combination cancer treatment |
| 11/24/2011 | US20110287092 Compositions comprising decitabine and tetrahydrouridine and uses thereof |
| 11/24/2011 | US20110287090 Compositions and Methods for Inhibiting Expression of a Mutant Gene |
| 11/24/2011 | US20110287089 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
| 11/24/2011 | US20110287088 Modulation of olfml-3 mediated angiogenesis |
| 11/24/2011 | US20110287085 Liposomal curcumin for treatment of cancer |
| 11/24/2011 | US20110287065 Nanoparticulate cinacalcet compositions |
| 11/24/2011 | US20110287058 Universal GM-CSF Expressing Bystander Human Cell Line |
| 11/24/2011 | US20110287057 Cancer Treatment |
| 11/24/2011 | US20110287056 Agents and methods to elicit anti-tumor immune response |
| 11/24/2011 | US20110287055 Compositions comprising prfa* mutant listeria and mehtods of use thereof |
| 11/24/2011 | US20110287049 Prevention and treatment of amyloidogenic diseases |
| 11/24/2011 | US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 11/24/2011 | US20110287042 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same |
| 11/24/2011 | US20110287038 Method for treating solid tumors |
| 11/24/2011 | US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| 11/24/2011 | US20110287036 Novel cancer targeting therapy using complex of subtance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound |
| 11/24/2011 | US20110287035 Method and composition for hyperthermally treating cells |
| 11/24/2011 | US20110287034 Therapeutic and diagnostic methods relating to cancer stem cells |
| 11/24/2011 | US20110287031 Covalently reactive transition state analogs and methods of use thereof |
| 11/24/2011 | US20110287026 Sirt4 and uses thereof |
| 11/24/2011 | US20110287025 Combination therapy and method for assessing resistance to treatment |
| 11/24/2011 | US20110287023 High Affinity Antibodies Against HMGB1 and Methods of Use Thereof |
| 11/24/2011 | US20110287021 Neoplasm specific antibodies and uses thereof |
| 11/24/2011 | US20110287020 Recombinant vectors |
| 11/24/2011 | US20110287016 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 11/24/2011 | US20110287011 DDR1-Binding Agents and Methods of Use Thereof |
| 11/24/2011 | US20110287006 Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
| 11/24/2011 | US20110287003 Treatment methods |
| 11/24/2011 | US20110287001 Method of treatment |
| 11/24/2011 | US20110286999 Methods for reversing multiple resistance in animal cells |
| 11/24/2011 | US20110286998 Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors |
| 11/24/2011 | US20110286980 Methods for inducing selective apoptosis |
| 11/24/2011 | US20110286979 CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA) |
| 11/24/2011 | US20110286973 Methods for introducing heterologous cells into fish |
| 11/24/2011 | US20110286972 Virus growing in hypoxic cell or virus vector expressing gene therein |
| 11/24/2011 | US20110286971 Targeted drug-carrying bacteriophages |
| 11/24/2011 | US20110286967 Long-acting interferons and derivatives thereof and methods thereof |
| 11/24/2011 | US20110286963 Human soluble cd146, preparation and uses thereof |
| 11/24/2011 | US20110286960 Cancer therapy by docetaxel and granulocyte colony-stimulating factor (g-csf) |
| 11/24/2011 | US20110286958 Hpma polymer platinum chelates |
| 11/24/2011 | US20110286936 Targeting vector-phospholipid conjugates |
| 11/24/2011 | US20110286935 Multi-Functional Nano-Device |
| 11/24/2011 | US20110286934 Membrane transduction peptides, polynucleotides, and methods |
| 11/24/2011 | US20110286930 Methods of identifying modulators of the pp2a b56 beta regulatory subunit |
| 11/24/2011 | US20110286928 Methods and compositions for inhibition of BCL6 repression |
| 11/24/2011 | US20110286927 ATF4 Inhibitors and Their Use for Neural Protection, Repair, Regeneration, and Plasticity |
| 11/24/2011 | US20110286924 Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer |
| 11/24/2011 | US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 11/24/2011 | US20110286922 Imaging and radiotherapy methods |
| 11/24/2011 | US20110286919 Conjugates of noscapine and folic acid and their use in treating cancer |
| 11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 11/24/2011 | US20110286917 Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer |
| 11/24/2011 | US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use |
| 11/24/2011 | US20110286915 Nanocarriers for Drug Delivery |
| 11/24/2011 | CA2837059A1 Cancer treatment |
| 11/24/2011 | CA2836315A1 Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas |
| 11/24/2011 | CA2816928A1 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles |